Cystic fibrosis-related diabetes testing in Belforte Monferrato
Find health labs to test for Cystic fibrosis-related diabetes in Belforte Monferrato and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Diabetes Test by Laboratorio Analisi Cliniche Valle Scrivia SRL - Busalla
Via Luigi Nino Malerba, 28, 16012 Busalla GE, Italia
14.4 km
Diabetes Test by Casa della Salute
Largo Milite Ignoto, 1, 16012 Busalla GE, Italia
14.4 km
Diabetes Test by Casa della Salute
Via Multedo di Pegli, 2C, 16155 Genova GE, Italia
19.9 km
Hemoglobin Test by Casa della Salute
Via Giacomo Poirè, 27, 16010 Sant'Olcese GE, Italia
17.9 km
Hemoglobin Test by Synlab Analsi Mediche
Via Piero Gobetti, 5, 16145 Genova GE, Italia
19.9 km
Hemoglobin Test by Laboratorio Analisi Cliniche Valle Scrivia SRL - Genova
Via Giuseppe Sapeto, 5A, 16132 Genova GE, Italia
19.9 km
Hemoglobin Test by Bianalisi - Punto prelievo Rapallo
Via Pellerano Murtula, 1, 16035 Rapallo GE, Italia
33.9 km
Hemoglobin Test by Lab - Analisi Cliniche
Via Paolo Borsellino, 1, 26865 San Rocco al Porto LO, Italia
59.8 km
Hemoglobin Test by Casa di Cura Ambrosiana
Piazza Monsignor Luigi Moneta, 18, 20090 Cesano Boscone MI, Italia
60.6 km
Diabetes Test by Irm - Indagini Ricerche Mediche
Via Torino, 19, 20123 Milano MI, Italia
63.7 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
